Cargando…

The influence on survival of delay in the treatment initiation of screening detected non-symptomatic breast cancer

We aimed to determine whether the detection-to-treatment interval of non-symptomatic breast cancer is associated with factors that can predict survival outcomes. A retrospective review of the Breast Surgery Department Database at Peking Union Medical College Hospital (PUMCH) was performed, and a tot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yan, Zhou, Yidong, Mao, Feng, Guan, Jinghong, Lin, Yan, Wang, Xuejing, Zhang, Yanna, Zhang, Xiaohui, Shen, Songjie, Sun, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6629625/ https://www.ncbi.nlm.nih.gov/pubmed/31308467 http://dx.doi.org/10.1038/s41598-019-46736-1

Ejemplares similares

Ultrasound-Assisted Thoracic Paravertebral Block Reduces Intraoperative Opioid Requirement and Improves Analgesia after Breast Cancer Surgery: A Randomized, Controlled, Single-Center Trial
por: Pei, Lijian, et al.
Publicado: (2015)

Predictors of nonsentinel lymph node metastasis in patients with breast cancer with metastasis in the sentinel node
por: Zhou, Yidong, et al.
Publicado: (2019)

Expression of ALDH1 in breast invasive ductal carcinoma: an independent predictor of early tumor relapse
por: Zhong, Ying, et al.
Publicado: (2013)

Rationale and design of a phase II trial of pyrotinib in combination with nab-paclitaxel as adjuvant therapy for N0/N1mi, HER2 + early breast cancer (PHAEDRA)
por: Wang, Changjun, et al.
Publicado: (2022)

Web-Based Medical Information Searching by Chinese Patients With Breast Cancer and its Influence on Survival: Observational Study
por: Li, Yan, et al.
Publicado: (2020)

Comparison of CTS5 risk model and 21-gene recurrence score assay in large-scale breast cancer population and combination of CTS5 and recurrence score to develop a novel nomogram for prognosis prediction
por: Wang, Changjun, et al.
Publicado: (2022)

Concurrent administration of trastuzumab and anthracyclines as adjuvant regimen for HER2-positive breast cancer: a randomised controlled trial
por: Shen, Songjie, et al.
Publicado: (2017)

NOTCH1 is a poor prognostic factor for breast cancer and is associated with breast cancer stem cells
por: Zhong, Ying, et al.
Publicado: (2016)

TTK is a favorable prognostic biomarker for triple-negative breast cancer survival
por: Xu, Qianqian, et al.
Publicado: (2016)

lncRNA AFAP1-AS1 promotes triple negative breast cancer cell proliferation and invasion via targeting miR-145 to regulate MTH1 expression
por: Zhang, Xiaohui, et al.
Publicado: (2020)

The Diagnostic Performance of Minimally Invasive Biopsy in Predicting Breast Pathological Complete Response After Neoadjuvant Systemic Therapy in Breast Cancer: A Meta-Analysis
por: Li, Yan, et al.
Publicado: (2020)

Pyrotinib with trastuzumab and aromatase inhibitors as first-line treatment for HER2 positive and hormone receptor positive metastatic or locally advanced breast cancer: study protocol of a randomized controlled trial
por: Wang, Changjun, et al.
Publicado: (2020)

Diagnostic Performance of Indocyanine Green-Guided Sentinel Lymph Node Biopsy in Breast Cancer: A Meta-Analysis
por: Zhang, Xiaohui, et al.
Publicado: (2016)

Efficacy and Safety of Anti-HER2 Agents in Combination With Chemotherapy for Metastatic HER2-Positive Breast Cancer Patient: A Network Meta-Analysis
por: Zhang, Xiaohui, et al.
Publicado: (2021)

Expression and function of MutT homolog 1 in distinct subtypes of breast cancer
por: Zhang, Xiaohui, et al.
Publicado: (2017)

A case report of primary angiosarcoma of the breast
por: Huang, Junying, et al.
Publicado: (2023)

Long-term survival of screen-detected synchronous and metachronous bilateral non-palpable breast cancer among Chinese women: a hospital-based study (2003–2017)
por: Pan, Bo, et al.
Publicado: (2022)

Long noncoding RNA AFAP1-AS1 promotes tumor progression and invasion by regulating the miR-2110/Sp1 axis in triple-negative breast cancer
por: Zhang, Xiaohui, et al.
Publicado: (2021)

The influence on survival of delay in the presentation and treatment of symptomatic breast cancer
por: Richards, M A, et al.
Publicado: (1999)

The impact of pre-existed and SERM-induced non-alcoholic fatty liver disease on breast cancer survival: a meta-analysis
por: Wang, Changjun, et al.
Publicado: (2020)

Omitting radiotherapy is safe in breast cancer patients ≥ 70 years old after breast-conserving surgery without axillary lymph node operation
por: Zhong, Ying, et al.
Publicado: (2020)

A nomogram for individually predicting overall survival for elderly patients with early breast cancer: a consecutive cohort study
por: Zhong, Ying, et al.
Publicado: (2023)

Mammographic casting-type calcification is an independent prognostic factor in invasive breast cancer
por: Li, Yan, et al.
Publicado: (2019)

GnRHa for Ovarian Protection and the Association between AMH and Ovarian Function during Adjuvant Chemotherapy for Breast Cancer
por: Zhong, Ying, et al.
Publicado: (2019)

Phosphatidylinositol-3,4,5-Trisphosphate Dependent Rac Exchange Factor 1 (PREX1) is a Novel Predictor of Prognosis for Breast Cancer Patients: A Retrospective Case Series
por: Zhong, Ying, et al.
Publicado: (2019)

Preliminary study of contrast-enhanced ultrasound in combination with blue dye vs. indocyanine green fluorescence, in combination with blue dye for sentinel lymph node biopsy in breast cancer
por: Zhou, Yidong, et al.
Publicado: (2019)

Would 1.0 cm be a more suitable cutoff to subdivide pT1 tumors in hormone receptor‐negative and HER2‐positive breast cancer?
por: Wang, Changjun, et al.
Publicado: (2018)

miR-452 Reverses Abnormal Glycosylation Modification of ERα and Estrogen Resistance in TNBC (Triple-Negative Breast Cancer) Through Targeting UGT1A1
por: Li, Yan, et al.
Publicado: (2020)

Association of striking life events with primary breast cancer in 265 Chinese women: a case-control study
por: Lin, Yan, et al.
Publicado: (2017)

Genetic factors associated with cancer racial disparity – an integrative study across twenty‐one cancer types
por: Li, Yan, et al.
Publicado: (2020)

Breast cancer pre-clinical screening using infrared thermography and artificial intelligence: a prospective, multicentre, diagnostic accuracy cohort study
por: Wang, Xuefei, et al.
Publicado: (2023)

Validation of CTS5 model in large-scale breast cancer population and the impact of menopausal and HER2 status on its prognostic value
por: Wang, Changjun, et al.
Publicado: (2020)

Breast-conserving surgery without axillary surgery and radiation versus mastectomy plus axillary dissection in elderly breast cancer patients: A retrospective study
por: Zhong, Ying, et al.
Publicado: (2023)

Influence of delayed initiation of adjuvant chemotherapy on breast cancer survival is subtype-dependent
por: Yu, Ke-Da, et al.
Publicado: (2016)

Ki‐67 index, progesterone receptor expression, histologic grade and tumor size in predicting breast cancer recurrence risk: A consecutive cohort study
por: Zhang, Yanna, et al.
Publicado: (2020)

Clinical characteristics and survival outcomes of patients with both primary breast cancer and primary ovarian cancer
por: Chen, Chang, et al.
Publicado: (2020)

A Prognostic Model of Triple-Negative Breast Cancer Based on miR-27b-3p and Node Status
por: Shen, Songjie, et al.
Publicado: (2014)

Cancer-derived exosomal miR-7641 promotes breast cancer progression and metastasis
por: Shen, Songjie, et al.
Publicado: (2021)

Nomogram prediction of the 70-gene signature (MammaPrint) binary and quartile categorized risk using medical history, imaging features and clinicopathological data among Chinese breast cancer patients
por: Pan, Bo, et al.
Publicado: (2023)

Molecular characteristics of screen-detected vs symptomatic breast cancers and their impact on survival
por: Dawson, S J, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_0bco8kr4ktsfrb8ut1agi2trjh